Scinai Immunotherapeutics Ltd. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Scinai Immunotherapeutics Ltd. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q1 | 2023 | Mar 31, 2023 | ($3.52M) | May 15, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($2.48M) | May 15, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q1 | 2023 | Mar 31, 2023 | ($3.19M) | May 15, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($2.62M) | May 15, 2023 |